Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
266M
-
Number of holders
-
152
-
Total shares
-
53M
-
Shares change
-
+962K
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
+$26M
-
Put/Call ratio
-
0.41
-
Number of buys
-
74
-
Number of sells
-
-74
-
Price
-
$21.87
Significant Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q2 2023
151 filings reported holding OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q2 2023.
Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53M shares
of 266M outstanding shares and own 19.92% of the company stock.
Largest 10 shareholders include FMR LLC (7.38M shares), JPMORGAN CHASE & CO (4.86M shares), VANGUARD GROUP INC (4.75M shares), BlackRock Inc. (3.53M shares), T. Rowe Price Investment Management, Inc. (3.17M shares), Bellevue Group AG (3.13M shares), Champlain Investment Partners, LLC (1.92M shares), MILLENNIUM MANAGEMENT LLC (1.88M shares), BRAIDWELL LP (1.46M shares), and AMERIPRISE FINANCIAL INC (1.42M shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.